Siqing Fu, M.D., Ph.D. MD Anderson Cancer Center discusses Soricimed Announces Resumption of MD Anderson"™s Investigator-Initiated Phase 1b Clinical Trial of SOR-C13
https://www.firstwordpharma.com/node/1731315
Advertisement
Siqing Fu, M.D., Ph.D. MD Anderson Cancer Center discusses Soricimed Announces Resumption of MD Anderson"™s Investigator-Initiated Phase 1b Clinical Trial of SOR-C13
https://www.firstwordpharma.com/node/1731315